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The effect of dietary variation of plasma cholesterol concentrations on the susceptibility of erythrocytes to in 
vitro and in vivo peroxidant stress was studied in rats. Malonyldialdehyde, produced in vivo (endogenous 
mafonyldialdehyde) or following in vitro exposure of cells to 10 mM H,O, (H,O, mafonyldiafdehyde), was 
used as a measure of peroxidant stress. After 5 weeks, the plasma cholesterol concentrations in rats receiving 
1.2% cholesterol + 0.6% cholic acid in their diet rose to 64mes that of control rats receiving a diet without 
added cholesterol; at the same time, erythrocyte H,O, malonyldialdehyde in the cholesterol-fed rats 
decreased significantly relative to the control rats. During subsequent exposure of both groups to in vivo 
pet-oxidant stress with phenylhydrazine in two separate dose trials, erythrocyte peroxidant stress remained 
significantly lower in the cholesterol-fed rats: at a dose of 100 umol/lOO g body weight, H,O, 
malonyldiafdehyde was lower; at a dose of 25 pmol/ 100 g body weight, both endogenous and H ,O, 
malonyldialdehyde were lower. Erythrocyte membrane cholesterol concentrations were 12% higher in the 
cholesterol-fed rats than in controls. The effects of in vivo peroxidant stress on plasma cholesterol were also 
studied. In vivo peroxidant stress at the higher dose of phenylhydrazine produced a decrease in plasma 
cholesterol concentrations of control rats. The lower dose had no effect on this group and the plasma 
cholesterol concentrations were unchanged in the cholesterol-fed rats during both treatments. The data 
suggest that elevated plasma cholesterol concentrations are protective against erythrocyte peroxidant stress. 
The mechanism of cholesterol’s protective effect is probably mediated through elevated membrane cholesterol 
concentrations. 
Introduction 
Recently, Jain and Shohet [l] reported that 
cholesterol is protective against oxidant stress; in 
vitro cholesterol-enriched erythrocytes were shown 
to be less susceptible to peroxidant stress than 
nonenriched cells. It was suggested that cholesterol 
* A preliminary communication of this work was presented at 
the Meetings of the Federation of American Societies for 
Experimental Biology, St. Louis, MO, 1984. and abstracted 
in Fed. Proc. 43. 796. 
acts as an oxidant radical scavenger and therefore 
protects adjacent membrane lipids from oxidative 
attack. 
The observed effect of cholesterol may have 
implications for patients with sickle cell anemia. 
Sickle erythrocytes are exposed to increased oxi- 
dant stress [2-41 and consequently undergo mem- 
brane damage. At the same time, the patients’ 
plasma cholesterol concentrations are low [5]. Since 
erythrocytes do not synthesize cholesterol and de- 
pend for renewal on exchange from the plasma, a 
low plasma cholesterol may be disadvantageous. If 
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so, a treatment approach aimed at increasing the 
size of the exchangeable pool of cholesterol in the 
plasma of these patients could be envisaged. 
Another implication associated with cholester- 
ol’s oxidant radical-scavenging action is that 
oxygenated derivatives of cholesterol would be 
formed, many of which have been identified as 
inhibitors of hepatic cholesterol synthesis [6-91. It 
has been suggested [lO,ll] that oxysterol forma- 
tion might explain the decreased plasma cholesterol 
concentrations in patients with sickle cell anemia. 
To test these ideas, we have studied the in vivo 
‘antioxidant’ effect of cholesterol in rats. First, 
plasma cholesterol concentrations were manipu- 
lated by dietary supplementations with either 
cholesterol, cholic acid, plus corn oil or corn oil 
alone to determine ,if variations in plasma 
cholesterol concentrations are associated with vari- 
ations in the susceptibility of erythrocytes to per- 
oxidant stress during in vitro and in vivo ex- 
posures. Second, the plasma cholesterol concentra- 
tions during in vivo peroxidant stress were moni- 
tored to determine if treatment would result in 
decreased concentrations of cholesterol in the 
plasma. 
Materials and Methods 
Animals. 20 weanling rats of the Sprague-Daw- 
ley strain were purchased from Charles River 
Laboratories. 
Diets. Two diets were used in this study: a 
control diet consisting of regular rat chow meal 
(No. 5012, Ralston-Purina, St. Louis, MO) supple- 
mented with 5.0% (by wt.) corn oil, and a test diet 
consisting of rat chow supplemented with 1.2% (by 
wt.) cholesterol, 0.6% (by wt.) cholic acid, and 
3.8% (by wt.) corn oil. 
The diets were prepared as follows: for the 
cholesterol-containing diet, an appropriate amount 
of cholesterol and corn oil were combined and 
preheated at 250°C for 10 min. Cholic acid was 
premixed with a small quantity of chow and added 
to the remaining chow together with the 
cholesterol/corn oil mixture and all the ingredi- 
ents were mixed for 15 min in a stainless steel 
Hobbart paddle mixer. The control diet was pre- 
pared similarly except that cholesterol and cholic 
acid were omitted. Both diets were prepared 
monthly and stored at 4’C at all times. 
Food intake was restricted, beginning with 13 
g/day the first week, then followed by 1 g incre- 
ments weekly up to 16 g/day. The food was 
weighed into individual dishes daily and mois- 
tened with distilled water immediately prior to 
feeding to minimize the spilling of foods by the 
rats. 
Experimental design. The rats were randomly 
assigned to a dietary treatment group of 10 rats 
each and housed individually. During the first 
week, the rats were fed unsupplemented chow to 
acclimate them to their cages and to the single 
daily dose feeding schedule of the moistened chow. 
On the first day of the dietary protocol, after an 
overnight fast, the animals were weighed, lightly 
anaesthetized and 2 ml of blood were withdrawn 
by cardiac puncture into heparinized syringes. 
Baseline values for hematocrit, hemoglobin, mal- 
onyldialdehyde and plasma cholesterol were de- 
termined. The diets were begun and continued for 
the duration of the study. After 5 weeks, blood 
samples were obtained and assayed as described. 
Following a 2-week recovery period, both groups 
were subjected to in vivo peroxidant stress with 
daily subcutaneous injections of phenylhydrazine 
at a dose of 100 pmol/lOO g body weight for 7 
days. Phenylhydrazine was dissolved in 0.154 M 
NaCl and adjusted to pH 7.4. On the first and 
subsequent alternate days of injection, 0.25-0.35 
ml blood samples were drawn into heparinized 
vials by tail clipping for the determination of 
hemoglobin and hematocrit. On the final day of 
phenylhydrazine administration, blood samples 
were obtained by cardiac puncture and analyzed 
for plasma cholesterol, malonyldialdehyde, hemo- 
globin and hematocrit. A 2-week recovery period 
was followed by a second exposure to peroxidant 
stress with phenylhydrazine at a dose of 25 pmol/ 
100 g body weight. As described for the higher 
dose, the rats were monitored for their hemato- 
logic status and, on the 7th day, were bled by 
cardiac puncture. In addition to the assays de- 
scribed, erythrocyte membrane cholesterol con- 
centrations were determined on samples drawn 
during the lower dose phenylhydrazine treatment 
period and on additional samples drawn 2 weeks 
later. 
Assays. Malonyldialdehyde was assayed accord- 
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ing to the method of Stocks and Dormandy [12]. 
Approx. 2 ml of whole blood were spun at 800 x g, 
the plasma and buffy coat were removed and the 
cells were washed 2 times with 10 mM Tris buffer 
in 0.154 M NaCl (pH 7.4) (the same buffer was 
used throughout this procedure and will be referred 
to simply as 10 mM Tris buffer). The washed cells 
(hematocrit, 50%) were adjusted to a hematocrit of 
4% in a 6.0 ml total volume as follows: 0.48 ml of 
cells were combined with 4.92 ml of 10 mM Tris 
buffer + 0.6 ml of 10 mM sodium azide dissolved 
in 10 mM Tris buffer. Following preincubation at 
37°C for 10 min in a water bath, 1 ml aliquots of 
each sample were pipetted into four separate tubes. 
One duplicate pair was used for endogenous 
malonyldialdehyde determination to which 1 ml of 
10 mM Tris was added; the other duplicate pair 
was used for H,O, malonyldialdehyde determina- 
tion to which 1 ml of 20 mM H,O, was added. 
The samples were mixed and then incubated at 
37°C for 1 h. Following addition of 1.0 ml of 28% 
trichloroacetic acid/l mM sodium arsenite in 10 
mM Tris buffer, the samples were spun at 33 500 
x g, for 5 min. To 2.0 ml of the supernatants, 0.5 
ml of 1.0% thiobarbituric acid/50 mM NaOH in 
10 mM Tris buffer was added. The samples were 
placed in a boiling water bath for 10 min, then 
cooled rapidly in cold water and the absorbances 
at 532 and 600 nm were recorded. The absorbance 
reading at 600 nm was subtracted from the read- 
ing at 532 nm; this difference and the molar 
extinction coefficient for malonyldialdehyde were 
used in calculating malonyldialdehyde concentra- 
tions. 
Plasma total cholesterol was assayed enzymati- 
tally using the Sigma Total Cholesterol Kit (No. 
350, St. Louis, MO): 10 ~1 of plasma or standard 
were combined with 1 ml of cholesterol enzymatic 
reagent and incubated at 37°C for 10 min. The 
absorbance at 500 nm was recorded for each sam- 
ple against a reagent blank. 
Erythrocyte membrane cholesterol was de- 
termined following extraction by a slightly mod- 
ified method of Rose and Oklander [13]. First, 1.0 
ml of packed cells was washed three times with 10 
mM Tris buffer in 0.154 M NaCl (pH 7.4). Then, 
1.0 ml distilled water was added and the samples 
were allowed to stand at 25°C for 15 min. Extrac- 
tion proceeded with the addition of 7.0 ml chloro- 
form followed by a 1 h standing period. then the 
addition of 11.0 ml isopropanol and an additional 
1 h standing period. The extract was spun at 
1100 X g for 30 min, the residue was discarded 
and cholesterol in the supernatant was measured 
by a modified Lieberman-Burchard procedure for 
serum or plasma cholesterol (Sigma, unpublished 
data). Either 1.0 ml of extract or 1 .O ml of 
cholesterol standard (diluted 1 : 1. v/v with isopro- 
panol) was evaporated to dryness under nitrogen. 
To the residues, 0.1 ml of water and 5.9 ml of 
cholesterol color reagent (Sigma No. 965-60) were 
added and the peak absorbance at 640 nm was 
recorded for each sample against a reagent blank 
containing 0.1 ml water and 5.9 ml of cholesterol 
color reagent. 
Hemoglobin was assayed by the cyanmethe- 
moglobin method. During periods of in vivo per- 
oxidant stress with phenylhydrazine, significant 
amounts of oxidized hemoglobin were formed 
which increased the turbidity of the samples. In 
this case, the diluted samples were first centrifuged 
at 3000 x g for 5 min and the absorbance of the 
supernatant at 540 nm was recorded. Hematocrits 
were measured by the microcapillary method. 
Reagents. Reagents were obtained from the fol- 
lowing sources: cholic acid (3,7,12_trihydroxy- 
cholanic acid), cholesterol (5(6)-cholesten-3-ol) 
USP grade, phenylhydrazine hydrochloride. 
cholesterol color reagent (Lieberman-Burchard. 
modified), total cholesterol enzymatic kit, and 
cholesterol aqueous standard from Sigma Chem- 
ical Company. St. Louis, MO; chloroform. 
methanol, and ethyl ether from Mallinckrodt. Paris. 
KY: all other reagents were of reagent grade. The 
corn oil was of commercial grade. 
Results 
Body growth 
A daily record of food consumption was main- 
tained for each rat. Since the rats were on a 
restricted, single-dose feeding regimen, they read- 
ily ate all of their food with one exception which 
occurred during the period of in vivo peroxidant 
stress with the higher dose of phenylhydrazine. In 
this instance, two or three rats in each group 
showed slight decreases in appetite, which re- 
turned to normal after the injections were stopped. 
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Fig. 1. Body weights of two dietary groups before and during in 
viva peroxidant stress. l , control group (diet containing 5.0% 
corn oil), 0, cholesterol group (diet containing 1.2% cholesterol, 
0.6% cholic acid and 3.8% corn oil), A, beginning of dietary 
protocol; B, period of in vivo peroxidant stress with 100 pmol 
phenylhydrazine/lOO g body weight; C, period of in vivo 
peroxidant stress with 25 pmol phenylhydrazine/lOO g body 
weight. 
This loss in appetite was not detectable as an 
abnormal body weight, since the weights increased 
steadily throughout the study and did not differ 
for the two groups (Fig. 1). 
Plasma cholesterol 
After 5 weeks of dietary protocol, the plasma 
cholesterol concentrations of both groups rose rel- 
ative to initial levels; however, the increase was 
more than lo-fold greater in the group consuming 
the diet supplemented with cholesterol and cholic 
acid (Table I). 
Both groups were subsequently exposed to in 
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TABLE I 
EFFECTS OF DIETS ON PLASMA CHOLESTEROL CON- 
CENTRATIONS 
Plasma cholesterol was assayed enzymatically using Sigma Total 
Cholesterol Kit. Results are means + S.D., * P < 0.001. 




control 10 38.7+ 4.3 
cholesterol 10 40.6+ 7.4 
control 10 58.4k 8.4 
cholesterol 10 304.2 + 128.1 * 
vivo peroxidant stress with phenylhydrazine in two 
separate dose trials. During the first treatment 
with 100 ~mol/lOO g body weight, the plasma 
cholesterol concentrations of the control group 
decreased relative to pretreatment levels, although 
significant only at P < 0.08; no change occurred 
in the cholesterol-fed group (Table IIA). During 
the second treatment with 25 pmol/lOO g body 
weight, the plasma cholesterol concentrations re- 
mained unchanged in both groups (Table IIB). 
Etythrocyte peroxidant stress 
The amount of thiobarbituric acid-reactive sub- 
stance formed, referred to here as malonyldialde- 
hyde, was used as a measure of erythrocyte peroxi- 
dant stress. Two determinations of oxidant stress 
were made on each sample: endogenous malonyl- 
dialdehyde which refers to malonyldialdehyde gen- 
erated by cells without added in vitro peroxidant 
stress and H,O, malonyldialdehyde which is a 
TABLE II 
PLASMA CHOLESTEROL CONCENTRATIONS DURING PHENYLHYDRAZINE TREATMENTS 
Phenylhydrazine was used to induce in vivo oxidant stress in two separate 7-day dose trials. Phenylhydrtine solutions, prepared in 
0.154 M NaCl and adjusted to pH 7.4, were administered daily by subcutaneous injections. Plasma cholesterol was assayed on days 1 
and 7 of each treatment period. The assay and dietary protocols are given in Materials and Methods. Results are means f S.D. 
Phenylhydrazine 
A. 100 pmol/lOO g body wt. 
B. 25 ~mol/lOO g body wt. 





Plasma cholesterol (mg/dl) 
pretreatment during treatment 
61.3+ 7.7 53.6f 10.9 
245.7 f 110.7 255.6 f 134.3 
53.7* 10.7 52.9k 5.8 
195.2& 29.8 190.1 f 74.6 
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measure of the susceptibility of erythocytes to 
peroxidant stress during in vitro exposure of cells 
to 10 mM H,O,. 
Before the dietary protocols were begun, the 
values for H,O, malonyldialdehyde were the same 
for the two groups: endogenous malonyldialde- 
hyde values were more variable, the difference 
between groups reaching significance (P -C 0.05) 
(Table III). However, after the rats had been on 
their respective diets for 5 weeks, endogenous 
malonyldialdehyde values declined in both groups 
and were not different from one another (Table 
III); H,O, malonyldialdehyde, on the other hand, 
decreased significantly (P < 0.001) in the 
cholesterol-fed group. 
In vivo peroxidant stress with phenylhydrazine 
(100 ~mol/lOO g body weight) produced a signifi- 
cant rise in both measures of malonyldialdehyde 
in both groups. Endogenous malonyldialdehyde 
did not differ for the dietary groups, while H,O, 
malonyldialdehyde was again significantly lower 
(84.5% of control; P < 0.025) in the cholesterol-fed 
group (Table III). Both groups became severely 
anemic during this treatment as seen by the low 
hemoglobin and hematocrit values in Table III. 
During a recovery period which followed this 
treatment, both groups regained normal hemato- 
logic status (data not shown). 
During the second exposure to in vivo peroxi- 
TABLE III 
dant stress at a reduced dose of phenylhydrazine 
(25 ~mol/lOO g body weight), hemolysis was less 
severe than at the higher dose: At this time, both 
endogenous and H,O, malonyldialdehyde were 
significantly lower (P 2 0.005 and P < 0.001. re- 
spectively) in the cholesterol-fed rats relative to 
controls (Table III). Endogenous malonyldialde- 
hyde was approx. 25% lower, and H,O, 
malonyldialdehyde approx. 12% lower in the 
cholesterol-fed rats. 
Membrane cholesterol 
Erythrocyte membrane cholesterol concentra- 
tions were determined after the final period of in 
vivo peroxidant stress using 25 pmol/lOO g body 
weight. Pooled samples were used for the analysis. 
The results showed that the erythrocytes from the 
cholesterol-fed group had substantially higher 
membrane cholesterol concentrations than the 
control group (1.12 vs. 0.92 mg/ml packed cells). 
A duplicate assay, performed on samples drawn 
two weeks later, gave similar results. Since only 
two samples were analyzed for each group, statisti- 
cal analysis was not carried out. 
Discussion 
The primary objective of this study was to 
determine if dietary variation of plasma cholesterol 
ERYTHROCYTE MALONYLDIALDEHYDE FORMATION BEFORE AND DURING IN VIVO PEROXIDANT STRESS 
Two assays were performed on each sample: for endogenous malonyldialdehyde (MDA), 1 ml of a 4% erythrocyte suspension (see 
Materials and Methods) was combined with 1 ml of 10 mM Tris buffer in 0.154 M NaCl (pH 7.4); for H,O, malonyldialdehyde 1 ml 
of the same suspension was combined with 1 ml of 20 mM H,O, in 10 mM Tris buffer. The samples were then assayed according to 
Stocks and Dormandy [12]. The results are means + S.D. Hct, hematocrit; Hb, hemoglobin. 
Period Dietary group n Hct Hb Endogenous MDA H,O, MDA 
(S) (g%) ( nmol/g Hb) ( n moI/g Hb) 
Baseline control 10 44.3 k 2.3 16.2k1.4 0.061 *O.OlO 1.957 of 0.076 
cholesterol 10 43.2+1.6 15.4k1.2 0.051 f 0.009 * 1.919 * 0.073 
Diet for 5 weeks control 10 43.4 + 3.2 14.1 * 1.2 0.032 + 0.005 1.873kO.155 
cholesterol 10 42.2 f 2.3 14.0*0.8 0.028 + 0.005 1.610+0.076 **** 
Phenylhydrazine control 10 30.3 k 3.2 6.4i0.8 0.090 + 0.010 3.269 f 0.282 * 
(100 ~moI/lOO g body wt.) cholesterol 10 27.7k2.8 6.4 k 0.5 0.086 + 0.022 b 2.768 f0.402 ‘.** 
Phenylhydrazine control 9 38.4+ 1.8 11.1+0.5 0.039 f 0.007 ‘I 1.694+0.112 h 
(25 nmol/lW g body wt.) cholesterol 10 35.4* 1.6 10.4kO.6 0.029kO.003 d.*** 1.498f0.064 h.**** 
“n=S; b n = 9; ’ n = 7. * P c 0.05; ** P < 0.025; *** P i 0.005; **** P -c 0.001; for cholesterol vs. control groups. 
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concentrations would be associated with variation 
in susceptibility of erythrocytes to peroxidant 
stress. Before the dietary treatments were begun, 
both groups were evaluated for endogenous and 
H,O, malonyldialdehyde (Table III, baseline 
period). A small, but significant mean difference 
in endogenous malonyldialdehyde between groups 
was detected which likely reflected the heterogene- 
ity of the rats used in these studies. After 5 weeks 
of dietary protocol, the rats receiving a diet supp- 
lemented with 1.2% cholesterol and 0.6% cholic 
acid had 6-fold higher plasma cholesterol con- 
centrations than rats receiving the control diet 
without added cholesterol (Table I). With the rise 
in cholesterol both measures of malonyldialdehyde 
decreased in both dietary teatment groups (Table 
III). Endogenous malonyldialdehyde values at this 
time were no longer different between the groups 
(Table III). In contrast, the mean H,O, 
malonyldialdehyde for cholesterol-fed rats was de- 
creased 14% relative to the mean for control rats, 
that is, the erythrocytes of the cholesterol-fed rats 
were less susceptible to in vitro peroxidant stress 
(Table III). A similar decrease in the susceptibility 
of erythrocytes to peroxidant stress was observed 
in the cholesterol-fed rats following in vivo peroxi- 
dant stress with phenylhydrazine at a dose of 100 
~mol/lOO g body weight (Table III). During a 
second, milder, exposure to in vivo peroxidant 
stress with phenylhydrazine (25 pmol/lOO g body 
weight), both measures of erythrocyte oxidant 
stress were lower in the cholesterol-fed group; 
endogenous malonyldialdehyde was approx. 25% 
lower, and H,O, malonyldialdehyde approx. 12% 
lower relative to control group values (Table III). 
A rise in erythrocyte membrane cholesterol con- 
centrations paralleled the rise in plasma cholesterol 
of the cholesterol-fed group. The results of dupli- 
cate assays revealed an average 12% higher mem- 
brane cholesterol concentration in rats of this 
group. 
The data suggest that elevated plasma 
cholesterol levels are associated with decreased in 
vitro and in vivo peroxidant stress of erythrocytes. 
This effect is probably mediated by elevated mem- 
brane cholesterol concentrations as shown by Jain 
and Shohet [l] with in vitro cholesterol-enriched 
human erythrocytes. The mechanism by which 
membrane cholesterol protects is uncertain. One 
possibility is that increased incorporation of 
cholesterol results in changes in the packing of 
phospholipids in such a way as to make them less 
accessible to oxidant radical attack. Another possi- 
bility, initially proposed by Jain and Shohet [l], is 
that cholesterol acts as an oxidant radical scavenger 
and thus protects adjacent membrane lipids from 
oxidation. A decrease in the degree of erythrocyte 
hemolysis would be expected from an elevated 
membrane cholesterol based on a reduction of 
membrane damage from lipid peroxidation. In the 
present study, hemolysis did not differ between 
groups during the oxidant stress of phenylhy- 
drazine administration. It is possible that the rats 
in the cholesterol-treated group were partially pro- 
tected against hemolysis, but that differences in 
hemolytic rate as evaluated by hemoglobin and 
hematocrit measurements were obscured by an 
increased erythroid response in the control rats. 
Measures of erythroid response or direct measures 
of hemolytic rate were not carried out in this 
study. 
If cholesterol was acting as a scavenger for 
oxidant radicals, oxidized derivatives of cholesterol 
would be formed, many of which have been identi- 
fied as inhibitors of hepatic cholesterol synthesis. 
Accordingly, a secondary objective of this study 
was to determine if in vivo peroxidant stress would 
result in decreased plasma cholesterol concentra- 
tions. During in vivo peroxidant stress at the higher 
dose of phenylhydrazine, the plasma cholesterol 
concentrations of control rats decreased, though 
not significantly and, during the lower dose phen- 
ylhydrazine treatment, the plasma cholesterol con- 
centrations remained unchanged. The phenylhy- 
drazine treatment had no effect on plasma 
cholesterol of cholesterol-fed rats, as expected, 
since dietary cholesterol is itself inhibitory [14-161. 
The present data from the control group, thus, is 
inconclusive with regard to increased oxygenated 
sterol formation during in vivo peroxidant stress. 
Irrespective of the mechanism by which cholesterol 
exerts its effect, our work indicates that elevated 
levels in the plasma are protective against 
erythrocyte peroxidant stress. 
The possible effect of corn oil on erythrocyte 
peroxidant stress was considered. It was added to 
the diets for caloric balance: 5% to the control 
diets and 3.8% to diets containing 1.2% cholesterol 
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(or approx. 10.5% and 8.0% of calories for control 
and test diets, respectively). Corn oil was chosen 
because it is a traditionally used source of fat in 
studies of dietary fat and because there is informa- 
tion in the literature on its effects. It has been 
shown that the fatty acid composition of various 
tissues, including the erythrocytes, can be altered 
by dietary fats [17-201. Dietary corn oil, in par- 
ticular, results in increases in membrane linoleic 
and arachidonic acids. Since linoleic acid can un- 
dergo lipid peroxidation in vivo [21], this raises the 
question whether the difference in the amount of 
corn oil added to the two diets resulted in a 
difference in the amount of linoleic acid incorpo- 
rated into the membrane and consequently 
accounts for the difference in erythrocyte oxidant 
stress. Data from studies on the effect of dietary 
corn oil on the erythrocyte membrane fatty acid 
profile [17-191 indicate that, in general, amounts 
of corn oil greater than the 5% used here are 
necessary to produce significant changes in 
erythrocyte fatty acids. Further, dietary corn oil at 
any level does not affect either the total lipid 
content or the proportion of lipid classes in the 
erythrocyte membrane. 
In light of these results, it is unlikely that the 
3.8 or 5.0% corn oil used in this study would have 
caused a significant increase in the linoleic acid 
content of erythrocytes. Even less likely is that the 
1.2% difference between the diets of the two groups 
would lead to a large enough difference in the 
incorporation of linoleic acid to influence lipid 
peroxidation. Endogenous malonyldialdehyde did 
not differ for the two dietary groups after 5 weeks 
of diets. Further, in Jain and Shohet’s study [l], 
manipulations of erythrocyte membrane cholester- 
ol concentrations were carried out in vitro without 
the effects of fatty acids. 
To summarize the results of our study: (1) they 
provide further evidence for cholesterol’s protec- 
tive effect against erythrocyte oxidant stress, (2) 
they demonstrate this protective effect in an animal 
model before and during in vivo peroxidant stress, 
and (3) they show that cholesterol’s protective 
effect can be manipulated through dietary varia- 
tions of plasma cholesterol concentration. These 
observations may have clinical relevance, for ex- 
ample, to patients with sickle cell anemia in whom 
plasma cholesterol concentrations are characteris- 
tically lower than normal, and erythrocytes un- 
dergo increased oxidant stress. The present data 
suggest that an elevated plasma cholesterol in these 
patients would ameliorate some of the membrane 
damage associated with the peroxidation of mem- 
brane lipids. 
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